Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Amarin Corporation plc - American Depositary Shares (NQ: AMRN )

11.18 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Amarin Corporation plc - American Depositary Shares

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Amarin to Present at SVB Securities Global Biopharma Conference
From Amarin Corporation plc
Via GlobeNewswire
Why Amarin Stock Tumbled This Week
Amarin's tussle with its largest stakeholder doesn't appear to be sitting well with shareholders. 
Via The Motley Fool
3 Penny Stocks to Sell in January Before They Peter Out
January has brought a major rally for penny stocks, but these three are likely to see their recent rallies evaporate in the coming weeks. 
Via InvestorPlace
Amarin Calls Activist Investor, Largest Shareholder Sarissa's Statement 'Inaccurate, Misleading'
Amarin Corporation Plc (NASDAQ: AMRN) reacted to its largest shareholder, Sarissa Capital Management, which said Amarin's recent board refreshment put "no shareholder representatives on the board." 
Via Benzinga
Amarin Responds to Inaccurate and Misleading Statement by Sarissa
From Amarin Corporation plc
Via GlobeNewswire
Why Amarin Stock Was a Winner Today
The product most readily identified with the company will soon hit pharmacy shelves in Australia. 
Via The Motley Fool
Amarin (AMRN) Q3 2022 Earnings Call Transcript
AMRN earnings call for the period ending September 30, 2022. 
Via The Motley Fool
Amarin Corp: Q3 Earnings Insights
Amarin Corp (NASDAQ:AMRN) reported its Q3 earnings results on Thursday, October 27, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Sarissa Capital Calls Out Amarin’s Sham Board Refreshment
From Sarissa Capital Management LP
Via Business Wire
Amarin Comments on Sarissa’s Notice to Call a Special Meeting of Amarin Shareholders
Highlights Significant Board Refreshment, Operational and Financial Improvements and Engagement with Sarissa Capital Management 
From Amarin Corporation plc
Via GlobeNewswire
Sarissa Capital Submits Notice to Call a Special Meeting of Amarin Shareholders to Add Directors and Remove Chairman Per Wold-Olsen
From Sarissa Capital Management LP
Via Business Wire
Amarin Provides Preliminary Fourth Quarter and Full Year 2022 Revenue and Cash Position and Priorities for 2023
From Amarin Corporation plc
Via GlobeNewswire
Why Bed Bath & Beyond Shares Are Trading Higher By 17%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers 
Via Benzinga
Amarin Board of Directors Announces Appointment of Murray W. Stewart, DM FRCP
From Amarin Corporation plc
Via GlobeNewswire
Amarin To Rally 138%? Here Are 10 Other Analyst Forecasts For Friday
Via Benzinga
Why Spruce Biosciences Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Gainers Swvl Holdings Corp. (NASDAQ: SWVL) surged 133% to $0.3218. Swvl recently announced the commencement of a strategic review process. 
Via Benzinga
Amarin to Present at the 41st Annual J.P. Morgan Healthcare Conference
From Amarin Corporation plc
Via GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For January 6, 2023
Via Benzinga
Amarin Announces VAZKEPA® (icosapent ethyl) Receives Regulatory Approval in Switzerland
From Amarin Corporation plc
Via GlobeNewswire
Amarin Announces VAZKEPA® (icosapent ethyl) Approved by the Therapeutic Goods Administration (TGA) in Australia
From Amarin Corporation plc
Via GlobeNewswire
Amarin to Present at Jefferies London Healthcare Conference
From Amarin Corporation plc
Via GlobeNewswire
Amarin Highlights Key Data Presented at American Heart Association 2022 Scientific Sessions for VASCEPA®/VAZKEPA (icosapent ethyl) and Patient Care
From Amarin Corporation plc
Via GlobeNewswire
Why Huadi International Group Shares Dipped Around 91%; Here Are 79 Biggest Movers From Yesterday
Gainers 
Via Benzinga
Amarin Corp Earnings Perspective: Return On Capital Employed
According to data from Benzinga Pro, during Q3, Amarin Corp's (NASDAQ:AMRN) reported sales totaled $89.88 million. Despite a 92.65% increase in earnings, the company posted a loss of $5.14 million. 
Via Benzinga
Why Oyster Point Pharma Shares Are Trading Higher By Around 40%? Here Are 49 Stocks Moving In Monday's Mid-Day Session
Gainers Dragon Victory International Limited (NASDAQ: LYL) surged 52.2% to $0.6870. 
Via Benzinga
Amarin Reports Third Quarter 2022 Financial Results and Provides Business Update
From Amarin Corporation plc
Via GlobeNewswire
Earnings Preview For Amarin Corp
Amarin Corp (NASDAQ:AMRN) is set to give its latest quarterly earnings report on Thursday, 2022-10-27. Here's what investors need to know before the announcement. Analysts estimate that Amarin Corp... 
Via Benzinga
Amarin Appoints Adam Berger and Geraldine Murphy to Board of Directors
From Amarin Corporation plc
Via GlobeNewswire
Amarin to Report Third Quarter 2022 Financial Results And Host Conference Call on October 27, 2022
From Amarin Corporation plc
Via GlobeNewswire
Amarin Board of Directors Issues Statement in Response to Sarissa
From Amarin Corporation plc
Via GlobeNewswire
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.